Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_20630 | 49 | 1.03 | Mlig455_015973 | Neo: - Age: - |
CHRND | Mlig455_015973 {REF} {Length: 1842} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=127.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=22.4]} {Human: ENSG00000135902, CHRND, cholinergic receptor nicotinic delta subunit, [Score=118, Expect=6e-29]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=115, Expect=5e-28]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=114, Expect=2e-27]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=114, Expect=2e-27]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=113, Expect=5e-27]} {Mouse: ENSMUSG00000026251, Chrnd, cholinergic receptor, nicotinic, delta polypeptide, [Score=117, Expect=2e-28]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=112, Expect=4e-27]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=112, Expect=4e-27]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=114, Expect=1e-27]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=123, Expect=5e-31]} {Smed: dd_Smed_v6_29533_0_1, dd_Smed_v6_29533_0_1, [Score=177, Expect=3e-51]} {RNA1310_42200} {RNA815_41928} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -4.352 | 1.327 | 1.00000 | 1.00000 | |
RegionR2 | 2.786 | 1.327 | 0.06790 | 0.31650 | |
RegionR3 | 1.249 | 1.327 | 0.36229 | 0.89789 | |
RegionR4 | -1.352 | 1.327 | 0.97603 | 1.00000 | |
RegionR5 | 0.723 | 1.327 | 0.54099 | 0.90370 | |
RegionR6 | 1.747 | 1.327 | 0.20420 | 0.77799 | |
RegionR7 | 2.747 | 1.327 | 0.04236 | 0.39533 | |
RegionR8 | -3.547 | 1.327 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.402 | 1.327 | 0.99996 | 1.00000 | |
RegenerationR2 | -0.576 | 1.327 | 0.38364 | 0.80381 | |
RegenerationR3 | -0.152 | 1.327 | 0.89896 | 1.00000 | |
RegenerationR4 | 0.863 | 1.327 | 0.41163 | 0.82156 | |
RegenerationR5 | 0.238 | 1.327 | 0.77509 | 0.98032 | |
RegenerationR6 | -1.792 | 1.327 | 0.13526 | 0.45109 | |
RegenerationBL | -3.697 | 1.327 | 1.00000 | 1.00000 | |
RegenerationTP | 1.183 | 1.327 | 0.57248 | 0.94585 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_20630 | 49 | 1.03 | Mlig455_015973 | Neo: - Age: - |
CHRND | 4 | - | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_015973 {REF} {Length: 1842} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=127.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=22.4]} {Human: ENSG00000135902, CHRND, cholinergic receptor nicotinic delta subunit, [Score=118, Expect=6e-29]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=115, Expect=5e-28]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=114, Expect=2e-27]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=114, Expect=2e-27]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=113, Expect=5e-27]} {Mouse: ENSMUSG00000026251, Chrnd, cholinergic receptor, nicotinic, delta polypeptide, [Score=117, Expect=2e-28]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=112, Expect=4e-27]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=112, Expect=4e-27]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=114, Expect=1e-27]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=123, Expect=5e-31]} {Smed: dd_Smed_v6_29533_0_1, dd_Smed_v6_29533_0_1, [Score=177, Expect=3e-51]} {RNA1310_42200} {RNA815_41928} |
2. | MligTC455_12113 | 72 | 1.5 | Mlig455_001687, Mlig455_071131 | Neo: - Age: - |
1.86 | - | - | - | 0.971 | 0.889 | - | Mlig455_001687 {REF} {Length: 809} {RNA1310_67367} {RNA815_37220} Mlig455_071131 {REF} {Length: 452} {RNA1509_45496} {RNA1310_67367} {RNA815_37220} |
|
3. | MligTC455_41289 | 88 | 1.84 | Mlig455_006035 | Neo: - Age: Up-Down-Down |
1.853 | - | - | - | 0.874 | 0.979 | - | Mlig455_006035 {REF} {Length: 1612} {RNA1509_22012} {RNA1310_42259} {RNA815_41617} | |
4. | MligTC455_05361 | 38 | 0.78 | Mlig455_067859 | Neo: - Age: - |
LHFPL6 | 1.82 | - | - | - | 0.824 | 0.996 | - | Mlig455_067859 {REF} {Length: 2249} {Pfam: Lipoma HMGIC fusion partner-like protein [PF10242.11, score=111.7]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=19.2]; Lipid II flippase MurJ [PF03023.16, score=19.0]} {Human: ENSG00000183722, LHFPL6, LHFPL tetraspan subfamily member 6, [RH, Score=80.9, Expect=5e-17]} {Mouse: ENSMUSG00000048332, Lhfp, lipoma HMGIC fusion partner, [RH, Score=79.0, Expect=2e-16]} {Smed: dd_Smed_v6_9373_0_1, dd_Smed_v6_9373_0_1, [RH, Score=179, Expect=1e-52]} {RNA1310_36894} {RNA815_56428} |
5. | MligTC455_45232 | 32 | 0.66 | Mlig455_067516 | Neo: - Age: Down-Up-Down |
SLC16A14 | 1.762 | - | - | - | 0.982 | - | 0.780 | Mlig455_067516 {REF} {Length: 2823} {Pfam: Major Facilitator Superfamily [PF07690.18, score=120.8]; Sugar (and other) transporter [PF00083.26, score=21.6]} {Human: ENSG00000163053, SLC16A14, solute carrier family 16 member 14, [Score=147, Expect=2e-37]} {Mouse: ENSMUSG00000026220, Slc16a14, solute carrier family 16 (monocarboxylic acid transporters), member 14, [Score=146, Expect=4e-37]} {Dmel: FBgn0023549, Mct1, Monocarboxylate transporter 1, [Score=311, Expect=4e-97]} {Celegans: WBGene00015676, mct-6, MonoCarboxylate Transporter family, [Score=300, Expect=3e-93]} {Smed: dd_Smed_v6_9402_0_1, dd_Smed_v6_9402_0_1, [Score=199, Expect=8e-56]} {RNA1509_49065} {RNA1310_24115} {RNA815_15685} |
6. | MligTC455_16199 | 114 | 2.37 | Mlig455_041013, Mlig455_041178 | Neo: Irradiation Age: - Region-enriched R2: 9.007/0.00037 |
1.726 | - | - | - | 0.953 | 0.773 | - | Mlig455_041013 {REF} {Length: 3381} {RNA1509_42904} {RNA1310_20434} {RNA815_22064} Mlig455_041178 {REF} {Length: 2722} {RNA1509_42904} {RNA1310_20004} {RNA815_22064} |
|
7. | MligTC455_32274 | 176 | 3.66 | Mlig455_041739 | Neo: - Age: - |
1.698 | - | - | - | 0.951 | 0.747 | - | Mlig455_041739 {REF} {Length: 1014} {Pfam: Adenovirus late L2 mu core protein (Protein X) [PF05829.14, score=30.0]} {RNA1509_21400} {RNA1310_6101.1} {RNA815_2733.1} | |
8. | MligTC455_46502 | 168 | 3.5 | Mlig455_010557 | Neo: - Age: - |
1.69 | - | - | - | 0.956 | 0.734 | - | Mlig455_010557 {REF} {Length: 557} {Pfam: HalX domain [PF08663.12, score=24.3]} {RNA1509_57107} {RNA1310_80026, RNA1509_57107} {RNA1509_57107, RNA815_41799} | |
9. | MligTC455_40791 | 75 | 1.56 | Mlig455_013501 | Neo: - Age: - Region-enriched R2: 7.804/0.01222 |
1.673 | - | - | - | 0.957 | 0.716 | - | Mlig455_013501 {REF} {Length: 2310} {Pfam: WSC domain [PF01822.21, score=57.5]; F5/8 type C domain [PF00754.27, score=52.4]; Clip-domain serine protease homolog Scarface [PF18399.3, score=20.3]} {Smed: dd_Smed_v6_52492_0_1, dd_Smed_v6_52492_0_1, [Score=58.5, Expect=2e-10]} {RNA1509_16751} {RNA1310_14302.1} {RNA815_6113.1} | |
10. | MligTC455_53233 | 1483 | 30.9 | Mlig455_037746, Mlig455_069921 | Neo: - Age: - Region-specific R2: 7.323 Region-enriched R2: 7.524/0.00000 Regeneration-downregulated R2: -3.635 Regeneration-depleted R2: -3.635 |
PKD2 | 1.668 | - | - | - | 0.954 | 0.714 | - | Mlig455_037746 {REF} {Length: 3024} {Pfam: Polycystin cation channel [PF08016.14, score=468.5]; Ion transport protein [PF00520.33, score=85.9]; EF-hand domain pair [PF13499.8, score=21.3]; EF hand [PF00036.34, score=21.2]; EF-hand domain [PF13405.8, score=18.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=708, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=306, Expect=2e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=379, Expect=1e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=719, Expect=0.0]} {RNA1509_30624, RNA1509_6992} {RNA1310_6033, RNA1509_30624} {RNA1509_30624, RNA815_1577.1} Mlig455_069921 {REF} {Length: 3030} {Pfam: Polycystin cation channel [PF08016.14, score=467.0]; Ion transport protein [PF00520.33, score=85.5]; EF hand [PF00036.34, score=21.3]; EF-hand domain pair [PF13499.8, score=21.3]; EF-hand domain [PF13405.8, score=18.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=707, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=304, Expect=8e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=377, Expect=3e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=716, Expect=0.0]} {RNA1509_6992} {RNA1310_6033, RNA1509_6992} {RNA1509_6992, RNA815_1577.1} |
11. | MligTC455_13375 | 48 | 1 | Mlig455_008269 | Neo: - Age: - Region-enriched R2: 6.043/0.00338 |
1.665 | - | - | - | 0.958 | - | 0.707 | Mlig455_008269 {REF} {Length: 2598} {RNA1310_27894} {RNA815_60961} | |
12. | MligTC455_09595 | 48 | 1.01 | Mlig455_030009 | Neo: - Age: - |
OPRM1 | 0.985 | - | - | - | 0.985 | - | - | Mlig455_030009 {REF} {Length: 1508} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=44.4]; Serpentine type 7TM GPCR chemoreceptor Sra [PF02117.18, score=19.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=19.6]} {Human: ENSG00000112038, OPRM1, opioid receptor mu 1, [Score=56.2, Expect=5e-08]} {Mouse: ENSMUSG00000000766, Oprm1, opioid receptor, mu 1, [Score=54.7, Expect=9e-08]} {Celegans: WBGene00021510, frpr-19, FMRFamide Peptide Receptor family, [Score=47.8, Expect=7e-06]} {RNA1310_43388} {RNA815_47203} |
13. | MligTC455_14625 | 12 | 0.24 | Mlig455_045049 | Neo: - Age: - |
0.982 | - | - | - | 0.982 | - | - | Mlig455_045049 {REF} {Length: 1923} | |
14. | MligTC455_14978 | 42 | 0.88 | Mlig455_016559 | Neo: - Age: - |
0.978 | - | - | - | 0.978 | - | - | Mlig455_016559 {REF} {Length: 1749} {NoTransDecoderORF} {RNA1509_56804} {RNA1310_36128, RNA1509_56804} {RNA1509_56804, RNA815_26038} | |
15. | MligTC455_46046 | 18 | 0.37 | Mlig455_042344 | Neo: - Age: - |
ASL | 0.976 | - | - | - | 0.976 | - | - | Mlig455_042344 {REF} {Length: 1218} {Pfam: Lyase [PF00206.22, score=41.7]; WSC domain [PF01822.21, score=31.1]} {Human: ENSG00000126522, ASL, argininosuccinate lyase, [Score=77.8, Expect=4e-16]} {Mouse: ENSMUSG00000025533, Asl, argininosuccinate lyase, [Score=76.3, Expect=8e-16]} {Dmel: FBgn0032076, CG9510, [Score=70.5, Expect=6e-14]} {Smed: dd_Smed_v6_3792_0_1, dd_Smed_v6_3792_0_1, [Score=86.7, Expect=9e-20]} {RNA1509_17568} {RNA1310_77268} {RNA815_37535} |
16. | MligTC455_12085 | 11 | 0.22 | Mlig455_058618 | Neo: - Age: - |
NPFFR2 | 0.968 | - | - | - | 0.968 | - | - | Mlig455_058618 {REF} {Length: 1772} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=137.1]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.1]; Olfactory receptor [PF13853.8, score=20.7]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=129, Expect=6e-32]} {Mouse: ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [Score=127, Expect=5e-32]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=169, Expect=1e-46]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=163, Expect=2e-45]} {Smed: dd_Smed_v6_16725_0_1, dd_Smed_v6_16725_0_1, [Score=248, Expect=3e-77]} |
17. | MligTC455_17440 | 269 | 5.59 | Mlig455_022945 | Neo: - Age: - |
0.968 | - | - | 0.968 | - | - | - | Mlig455_022945 {REF} {Length: 788} {NoTransDecoderORF} {RNA1310_20946} {RNA815_22699.1} | |
18. | MligTC455_13165 | 181 | 3.77 | Mlig455_018648 | Neo: - Age: - Region-specific R2: 6.131 Region-enriched R2: 4.463/0.01828 Regeneration-downregulated R2: -3.253 Regeneration-depleted R2: -3.253 |
0.966 | - | - | - | 0.966 | - | - | Mlig455_018648 {REF} {Length: 1920} {TRANSSPLICED} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_25789} {RNA1310_15994} {RNA815_21830} | |
19. | MligTC455_13166 | 186 | 3.88 | Mlig455_018849 | Neo: - Age: - Region-specific R2: 6.227 |
0.966 | - | - | - | 0.966 | - | - | Mlig455_018849 {REF} {Length: 693} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_49819} {RNA1310_28647} {RNA815_1682.1} | |
20. | MligTC455_13063 | 16 | 0.33 | Mlig455_014773 | Neo: - Age: - |
LRRC73 | 0.964 | - | - | - | - | 0.964 | - | Mlig455_014773 {REF} {Length: 1587} {TRANSSPLICED} {Pfam: Leucine Rich repeat [PF13516.8, score=38.3]} {Human: ENSG00000204052, LRRC73, leucine rich repeat containing 73, [RH, Score=120, Expect=4e-31]} {Mouse: ENSMUSG00000071073, Lrrc73, leucine rich repeat containing 73, [RH, Score=120, Expect=3e-31]} {RNA1509_57279} {RNA1310_21658, RNA1509_57279} {RNA1509_57279, RNA815_5530.1} |
21. | MligTC455_32591 | 24 | 0.49 | Mlig455_055614 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_055614 {REF} {Length: 5666} {RNA1509_50311} {RNA1310_1521.1} {RNA815_920.1} | |
22. | MligTC455_50582 | 22 | 0.46 | Mlig455_015496 | Neo: - Age: - |
0.963 | - | - | - | 0.963 | - | - | Mlig455_015496 {REF} {Length: 675} {RNA1509_48973} {RNA1310_27704} {RNA815_36286} | |
23. | MligTC455_17760 | 148 | 3.08 | Mlig455_016871 | Neo: - Age: - |
GDF6 | 0.961 | - | - | - | 0.961 | - | - | Mlig455_016871 {REF} {Length: 1578} {Pfam: Transforming growth factor beta like domain [PF00019.22, score=97.5]} {Human: ENSG00000156466, GDF6, growth differentiation factor 6, [RH, Score=118, Expect=5e-32]; ENSG00000125965, GDF5, growth differentiation factor 5, [RH, Score=114, Expect=2e-30]} {Mouse: ENSMUSG00000051279, Gdf6, growth differentiation factor 6, [RH, Score=119, Expect=1e-32]} {Dmel: FBgn0000490, dpp, decapentaplegic, [Score=121, Expect=5e-33]} {Celegans: WBGene00000936, dbl-1, DPP/BMP-Like; Decapentaplegic protein homolog, [RH, Score=120, Expect=1e-33]} {Smed: dd_Smed_v6_17402_0_1, dd_Smed_v6_17402_0_1, [RH, Score=124, Expect=4e-35]} {RNA1509_28282} {RNA1310_6507.1} {RNA815_15811} |
24. | MligTC455_35124 | 780 | 16.25 | Mlig455_059030, Mlig455_070853 | Neo: - Age: Down-Up-Down Region-enriched R6: 6.026/0.00025 |
0.961 | - | - | - | 0.961 | - | - | Mlig455_059030 {REF} {Length: 944} {Pfam: Dynein light chain type 1 [PF01221.20, score=58.7]; EF-hand domain pair [PF13499.8, score=25.4]; EF hand [PF00036.34, score=21.8]; EF-hand domain [PF14658.8, score=20.5]; EF-hand domain [PF13405.8, score=19.8]} {Smed: dd_Smed_v6_6707_0_3, dd_Smed_v6_6707_0_3, [Score=128, Expect=6e-38]} {RNA1509_37636} {RNA1310_36928, RNA1509_37636} {RNA1509_37636, RNA815_25288} Mlig455_070853 {REF} {Length: 962} {Pfam: Dynein light chain type 1 [PF01221.20, score=58.8]; EF-hand domain pair [PF13499.8, score=25.6]; EF-hand domain [PF13405.8, score=21.1]; EF hand [PF00036.34, score=21.0]; EF-hand domain [PF14658.8, score=20.2]} {Smed: dd_Smed_v6_6707_0_3, dd_Smed_v6_6707_0_3, [Score=127, Expect=7e-38]} {RNA1509_37636} {RNA1310_36928} {RNA815_25288} |
|
25. | MligTC455_51304 | 78 | 1.63 | Mlig455_027579 | Neo: - Age: - |
CTSA | 0.961 | - | - | - | 0.961 | - | - | Mlig455_027579 {REF} {Length: 3047} {Pfam: Serine carboxypeptidase [PF00450.24, score=324.1]} {Human: ENSG00000064601, CTSA, cathepsin A, [Score=178, Expect=3e-48]} {Mouse: ENSMUSG00000017760, Ctsa, cathepsin A, [Score=175, Expect=2e-47]} {Dmel: FBgn0038738, CG4572, [RH, Score=120, Expect=8e-29]} {Celegans: WBGene00019605, ctsa-1, Uncharacterized serine carboxypeptidase ctsa-1, [Score=197, Expect=6e-56]} {Smed: dd_Smed_v6_785_0_1, dd_Smed_v6_785_0_1, [Score=203, Expect=1e-57]} {RNA1310_57245} {RNA815_58201} |
26. | MligTC455_12037 | 183 | 3.81 | Mlig455_016647, Mlig455_016711 | Neo: - Age: Down-Up-Up |
DYNLL1 | 0.96 | - | - | - | 0.960 | - | - | Mlig455_016647 {REF} {Length: 879} {Pfam: Dynein light chain type 1 [PF01221.20, score=69.4]} {Human: ENSG00000088986, DYNLL1, dynein light chain LC8-type 1, [Score=62.8, Expect=7e-14]; ENSG00000264364, DYNLL2, dynein light chain LC8-type 2, [Score=60.1, Expect=7e-13]} {Mouse: ENSMUSG00000009013, Dynll1, dynein light chain LC8-type 1, [Score=62.8, Expect=4e-14]; ENSMUSG00000020483, Dynll2, dynein light chain LC8-type 2, [Score=60.1, Expect=5e-13]} {Dmel: FBgn0011760, ctp, cut up, [Score=60.5, Expect=2e-13]} {Celegans: WBGene00001005, dlc-1, Dynein light chain 1, cytoplasmic, [Score=59.3, Expect=6e-13]} {Smed: dd_Smed_v6_10084_0_2, dd_Smed_v6_10084_0_2, [Score=65.9, Expect=1e-15]} {RNA1509_36890} {RNA1310_30005} {RNA815_41098} Mlig455_016711 {REF} {Length: 890} {Pfam: Dynein light chain type 1 [PF01221.20, score=69.4]} {Human: ENSG00000088986, DYNLL1, dynein light chain LC8-type 1, [Score=62.8, Expect=5e-14]; ENSG00000264364, DYNLL2, dynein light chain LC8-type 2, [Score=60.1, Expect=7e-13]} {Mouse: ENSMUSG00000009013, Dynll1, dynein light chain LC8-type 1, [Score=62.8, Expect=4e-14]; ENSMUSG00000020483, Dynll2, dynein light chain LC8-type 2, [Score=60.1, Expect=5e-13]} {Dmel: FBgn0011760, ctp, cut up, [Score=60.8, Expect=2e-13]} {Celegans: WBGene00001005, dlc-1, Dynein light chain 1, cytoplasmic, [Score=59.3, Expect=5e-13]} {Smed: dd_Smed_v6_10084_0_5, dd_Smed_v6_10084_0_5, [Score=65.9, Expect=1e-15]} {RNA1509_36890} {RNA1310_30005} {RNA815_41098} |
27. | MligTC455_50827 | 107 | 2.22 | Mlig455_037867 | Neo: - |
WSCD2 | 0.96 | - | - | - | 0.960 | - | - | Mlig455_037867 {REF} {Length: 912} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.8, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=50.4, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=53.9, Expect=4e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=53.9, Expect=2e-08]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=46.2, Expect=8e-06]} {RNA1509_59284} {RNA1310_52794.1} {RNA815_21749.1} |
28. | MligTC455_57444 | 12 | 0.24 | Mlig455_043370 | Neo: - Age: - |
0.957 | - | - | - | 0.957 | - | - | Mlig455_043370 {REF} {Length: 290} {NoTransDecoderORF} | |
29. | MligTC455_15536 | 41 | 0.86 | Mlig455_030649 | Neo: - Age: - |
0.956 | - | - | - | 0.956 | - | - | Mlig455_030649 {REF} {Length: 1146} {RNA1310_33769.1} {RNA815_16068} | |
30. | MligTC455_15890 | 18 | 0.38 | Mlig455_059636 | Neo: - Age: - |
CD209 | 0.956 | - | - | - | 0.956 | - | - | Mlig455_059636 {REF} {Length: 1223} {Pfam: Lectin C-type domain [PF00059.23, score=29.7]} {Human: ENSG00000090659, CD209, CD209 molecule, [Score=49.3, Expect=2e-06]} {Dmel: FBgn0040096, lectin-33A, [Score=48.9, Expect=6e-07]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=64.7, Expect=2e-12]} {RNA1509_20946} {RNA1310_53178} {RNA815_42043} |
31. | MligTC455_40142 | 75 | 1.57 | Mlig455_022108 | Neo: - Age: - |
RAB37 | 0.956 | - | - | - | - | 0.956 | - | Mlig455_022108 {REF} {Length: 1460} {Pfam: Ras family [PF00071.24, score=174.5]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=101.6]; ADP-ribosylation factor family [PF00025.23, score=48.9]; 50S ribosome-binding GTPase [PF01926.25, score=23.6]} {Human: ENSG00000172794, RAB37, RAB37, member RAS oncogene family, [RH, Score=204, Expect=8e-66]; ENSG00000167964, RAB26, RAB26, member RAS oncogene family, [RH, Score=197, Expect=7e-62]} {Mouse: ENSMUSG00000020732, Rab37, RAB37, member RAS oncogene family, [RH, Score=202, Expect=2e-64]; ENSMUSG00000079657, Rab26, RAB26, member RAS oncogene family, [RH, Score=197, Expect=4e-62]} {Dmel: FBgn0086913, Rab26, [Score=187, Expect=7e-57]} {Celegans: WBGene00004285, rab-37, RAB family, [Score=166, Expect=1e-50]} {Smed: dd_Smed_v6_3485_0_1, dd_Smed_v6_3485_0_1, [Score=169, Expect=4e-52]} {RNA1310_81029} {RNA815_42257} |
32. | MligTC455_13259 | 11 | 0.23 | Mlig455_026238, Mlig455_042504 | Neo: - Age: - |
KREMEN1 | 0.954 | - | - | - | 0.954 | - | - | Mlig455_026238 {REF} {Length: 468} Mlig455_042504 {REF} {Length: 806} {Pfam: WSC domain [PF01822.21, score=46.2]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=51.6, Expect=3e-07]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=49.3, Expect=9e-07]} {RNA1310_57841} {RNA815_19006.2} |
33. | MligTC455_33442 | 39 | 0.81 | Mlig455_039767 | Neo: - Age: - |
0.954 | - | - | - | 0.954 | - | - | Mlig455_039767 {REF} {Length: 1975} {RNA1310_42391} | |
34. | MligTC455_17644 | 182 | 3.8 | Mlig455_007930, Mlig455_008033 | Neo: - Age: - |
0.953 | - | - | - | 0.953 | - | - | Mlig455_007930 {REF} {Length: 2086} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.9]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=3e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} Mlig455_008033 {REF} {Length: 1974} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.6]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=4e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} |
|
35. | MligTC455_18384 | 52 | 1.08 | Mlig455_033464, Mlig455_033480 | Neo: - Age: - |
CHRNB3 | 0.953 | - | - | - | 0.953 | - | - | Mlig455_033464 {REF} {Length: 3273} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=101.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=28.0]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=112, Expect=2e-26]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=107, Expect=4e-25]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=102, Expect=2e-23]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=95.5, Expect=5e-21]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=98.2, Expect=5e-22]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [Score=90.5, Expect=1e-19]} {RNA1509_28510} {RNA1310_44183.1} {RNA815_32188} Mlig455_033480 {REF} {Length: 904} {RNA1310_131495} |
36. | MligTC455_20088 | 39 | 0.81 | Mlig455_017821 | Neo: - Age: Up-Down-Down |
GLIPR1 | 0.953 | - | - | - | 0.953 | - | - | Mlig455_017821 {REF} {Length: 2083} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=62.2]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [Score=89.4, Expect=2e-19]} {Mouse: ENSMUSG00000025431, Crisp1, cysteine-rich secretory protein 1, [RH, Score=84.3, Expect=5e-18]} {Dmel: FBgn0038126, CG8483, [Score=54.3, Expect=1e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=78.6, Expect=5e-16]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=143, Expect=7e-37]} {RNA1310_43937.1} {RNA815_38891} |
37. | MligTC455_45569 | 10 | 0.2 | Mlig455_050997 | Neo: - Age: - |
NPFFR2 | 0.952 | - | - | - | 0.952 | - | - | Mlig455_050997 {REF} {Length: 1679} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=95.0]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=74.7, Expect=9e-14]; ENSG00000102239, BRS3, bombesin receptor subtype 3, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000031130, Brs3, bombesin-like receptor 3, [Score=72.0, Expect=4e-13]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=69.3, Expect=2e-12]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=68.6, Expect=5e-12]; ENSMUSG00000031364, Grpr, gastrin releasing peptide receptor, [Score=68.6, Expect=4e-12]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [Score=84.7, Expect=3e-17]} {Celegans: WBGene00006576, tkr-1, Probable G-protein coupled receptor tkr-1, [Score=65.9, Expect=2e-11]} {Smed: dd_Smed_v6_15625_0_1, dd_Smed_v6_15625_0_1, [Score=76.6, Expect=6e-15]} |
38. | MligTC455_11063 | 3 | 0.07 | Mlig455_017014 | Neo: - Age: - |
BARHL2 | 0.951 | - | - | - | 0.951 | - | - | Mlig455_017014 {REF} {Length: 2604} {Pfam: Homeodomain [PF00046.31, score=75.5]} {Human: ENSG00000143032, BARHL2, BarH like homeobox 2, [Score=88.2, Expect=8e-19]} {Mouse: ENSMUSG00000034384, Barhl2, BarH like homeobox 2, [Score=88.6, Expect=4e-19]} {Dmel: FBgn0054031, CG34031, [RH, Score=125, Expect=5e-34]} {Celegans: WBGene00000442, ceh-19, Homeobox protein ceh-19, [RH, Score=130, Expect=2e-36]} {Smed: dd_Smed_v6_72647_0_1, dd_Smed_v6_72647_0_1, [RH, Score=138, Expect=9e-39]} |
39. | MligTC455_46043 | 62 | 1.3 | Mlig455_042332 | Neo: - |
0.95 | - | - | - | 0.950 | - | - | Mlig455_042332 {REF} {Length: 1761} {Pfam: WSC domain [PF01822.21, score=47.9]; PAN domain [PF00024.28, score=19.6]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=46.2, Expect=8e-06]} {RNA1509_32911} {RNA1310_59750} {RNA815_37535} |